FdaApplication
NDA 021453
Identifiers
- fda_app_no: NDA021453
Properties
| Property | Value |
|---|---|
| applicant_name | BRISTOL MYERS SQUIBB CO |
| application_type | NDA |
| approval_date | 2002-12-31 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZERIT XR | STAVUDINE | 37.5MG | CAPSULE, EXTENDED RELEASE;ORAL |
| ZERIT XR | STAVUDINE | 50MG | CAPSULE, EXTENDED RELEASE;ORAL |
| ZERIT XR | STAVUDINE | 75MG | CAPSULE, EXTENDED RELEASE;ORAL |
| ZERIT XR | STAVUDINE | 100MG | CAPSULE, EXTENDED RELEASE;ORAL |
4 products